are some of the leading enterprises operating in the market.
Authors:
Mariam Faizullabhoy , Pratiksha Kamthe
Frequently Asked Questions (FAQ) :
Urinalysis industry was valued at USD 3.8 billion in 2022 and is expected to exhibit 5.2% CAGR from 2023 to 2032 owing to the increasing demand for better diagnostic and treatment techniques to treat the rising incidence rate of urinary tract infections globally.
Urinalysis industry size from the consumables product segment amassed USD 2.7 billion in 2022 and is poised to expand at 4.6% CAGR from 2023-2032 owing to the growing technological improvements.
North America held 36% share of the global urinalysis market in 2022 and is expected to expand at notable pace through 2032 driven by the strong presence of key market players and well-established healthcare systems.
Some of the top companies operating in the urinalysis industry are Bio-Rad Laboratories, Inc, Cardinal Health, ARKRAY Inc., ACON Laboratories, Inc., Abbott Laboratories, Sysmex Corporation, Teco Diagnostics, Erba Mannheim, Siemens Healthineers, 77 Elektronika Kft, and F.Hoffmann-La Roche Ltd.